JPRN-UMIN000041135
Recruiting
未知
Development of Artificial Intelligence (AI) to accelerate Drug Target discovery - Development of Artificial Intelligence (AI) to accelerate Drug Target discovery
ational Institutes of Biomedical Innovation, Health and Nutrition0 sites3,700 target enrollmentJuly 17, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Interstitial Lung Disease including IPF (Idiopathic Pulmonary Fibrosis) Lung Cancer
- Sponsor
- ational Institutes of Biomedical Innovation, Health and Nutrition
- Enrollment
- 3700
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\*Interstitial pneumonia including IPF (including suspicion) Patients who were judged to be unsuitable for participating in this study by the doctor in charge. \*Lung cancer nothing special
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The difference between the patient selection for AFCA using AI algorithm and the clinical guidelines-based decision will be compared and evaluated in terms of long-term rhythm outcome.KCT0008141Yonsei University Health System, Severance Hospital1,000
Recruiting
Not Applicable
Study of AI-Driven Imaging Markers for Early Dementia Diagnosis and PrognosisMental and behavioural disordersKCT0008720Konkuk University Medical Center91
Active, not recruiting
Not Applicable
Pathology AI PlatformKCT0003460Seoul National University Hospital6,200
Recruiting
Not Applicable
Research on artificial intelligence development for classification of oral histopathologyOral squamous cell carcinomaJPRN-jRCT1060220025Sukegawa Shintaro6
Not yet recruiting
Not Applicable
Research for Development of Artificial Intelligence-enhanced Electrocardiogram of Prediction fo r Mortality and Cardiovascular Outcomes using system of the National Health Insurance Service DatabaseNot ApplicableKCT0008493Inha University Hospital300,000